L-DOPA Association with Reduced Detection of New-Onset GA
Source: Eye and Vision, 2024 Background Geographic atrophy (GA) is a significant cause of vision loss in patients with age-related macular degeneration (AMD). Current treatments are limited to anti-complement drugs, which have limited efficacy to delay progression with significant risk of complications. Levodopa (L-DOPA) is a byproduct of melanin synthesis that is associated with reduced…
Read MoreAdditional Patents Licensed for Use
(a) United States Patent Number U.S. 11,969,401 entitled •compositions and Methods for Treating or Limiting Development of Age-Related Macular Degeneration· issued on April 30, 2024 {ARIZONA Ref No. UA19-094); and (b) United States Patent Number U.S. 9,173,862 entitled “Methods and Compositions for Treating and Identifying Compounds to Treat Age-Related Macular Degeneration” issued on November 3,…
Read MoreRole of L-DOPA in Prevention of GA
Source: Eye and Vision, 2024 Background Geographic atrophy (GA) is a significant cause of vision loss in patients with age-related macular degeneration (AMD). Current treatments are limited to anti-complement drugs, which have limited efficacy to delay progression with significant risk of complications. Levodopa (L-DOPA) is a byproduct of melanin synthesis that is associated with reduced…
Read MoreUS Patent 9,173,862 for MaculaPM™
METHODS AND COMPOSITIONS FOR TREATING AND IDENTIFYING COMPOUNDS TO TREAT AGE-RELATED MACULAR DEGENERATION
Read MoreUS Patent 9,861,600 for MaculaPM™
METHODS AND COMPOSITIONS FOR TREATING AND IDENTIFYING COMPOUNDS TO TREAT AGE-RELATED MACULAR DEGENERATION TREATMENT
Read MoreUS Patent 11,969,401 for MaculaPM™
COMPOSITIONS AND METHODS FOR TREATING OR LIMITING DEVELOPMENT OF AGE-RELATED MACULAR DEGENERATION
Read MoreEuropean Patent for MaculaPM™
Australian Patent for MaculaPM™
Warnings Before Taking MaculaPM™
As with any supplement, if you are pregnant, nursing, taking medications, have a medical condition or have difficulty swallowing, consult your doctor before use. Warning Language for L-Dopa: If you are taking medications (especially methyldopa, tricyclic antidepressants, or MAOIs) or have a medical condition including a history of melanoma, diabetes, peptic ulcer, liver disease, psychiatric…
Read MoreDifferent Therapeutic Approaches for AMD
Source: Department of Drug Sciences, Section of Pharmacology, University of Pavia Abstract: Age-related macular degeneration (AMD) is the most common cause of irreversible loss of central vision in elderly subjects, affecting men and women equally. It is a degenerative pathology that causes progressive damage to the macula, the central and most vital part of the…
Read More